AbCellera Biologics Inc vs Sprott Uranium Miners ETF — how do they compare? AbCellera Biologics Inc trades at $9.2 (market cap $2.99B), while Sprott Uranium Miners ETF trades at $55.96. The key difference: AbCellera Biologics Inc is trading nearer its 52-week high, Sprott Uranium Miners ETF nearer its low. Which is the better fit depends on your goals.
| ABCL | URNM | |
|---|---|---|
Market Cap | $2.99B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $9.76 | $83.99 |
52-Week Low | $2.78 | $44.14 |
Enterprise Value | $2.58B | — |
Trailing returns across standard periods
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →URNM is a pure-play ETF that invests in the global uranium industry. It provides exposure to companies involved in the mining, exploration, and production of uranium, as well as physical uranium holdings, with top assets like Cameco, Uranium Energy Corp, and the Sprott Physical Uranium Trust.
Read more on URNM →